DADC
CDLX icon

D.A. Davidson & Co’s Cardlytics CDLX Stock Holding History

D.A. Davidson & Co’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,533
Closed -$1.95M – 1215
2021
Q2 		$1.95M Buy
1,533
+421
+38% +$475K 0.02% 439
2021
Q1 		$1.22M Sell
1,112
-30
-3% -$39.6K 0.02% 534
2020
Q4 		$1.63M Buy
1,142
+54
+5% +$57.6K 0.02% 384
2020
Q3 		$768K Buy
1,088
+103
+10% +$74.9K 0.01% 519
2020
Q2 		$689K Buy
985
+24
+2% +$13.9K 0.01% 521
2020
Q1 		$336K Sell
961
-278
-22% -$197K 0.01% 697
2019
Q4 		$779K Sell
1,239
-540
-30% -$264K 0.01% 569
2019
Q3 		$596K Buy
+1,779
New +$570K 0.01% 619

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.A. Davidson & Co's CDLX Position: Q3 2021 in Review

D.A. Davidson & Co sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 1,533 shares — an estimated $1.95M sold.

D.A. Davidson & Co first reported a position in CDLX in Q3 2019 and held it in 8 quarters. The position peaked at $1.95M in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • D.A. Davidson & Co reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,533 Cardlytics shares in Q3 2021, an estimated $1.95M.
  • D.A. Davidson & Co first reported a position in Cardlytics in Q3 2019 and held it in 8 quarters.
  • D.A. Davidson & Co's Cardlytics position peaked at $1.95M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on D.A. Davidson & Co's 13F filing for Q3 2021, filed 15 Nov 2021.